1. Home
  2. GOGL vs MYGN Comparison

GOGL vs MYGN Comparison

Compare GOGL & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GOGL
  • MYGN
  • Stock Information
  • Founded
  • GOGL N/A
  • MYGN 1991
  • Country
  • GOGL Bermuda
  • MYGN United States
  • Employees
  • GOGL N/A
  • MYGN N/A
  • Industry
  • GOGL Marine Transportation
  • MYGN Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • GOGL Consumer Discretionary
  • MYGN Health Care
  • Exchange
  • GOGL Nasdaq
  • MYGN Nasdaq
  • Market Cap
  • GOGL 1.8B
  • MYGN 2.0B
  • IPO Year
  • GOGL 1997
  • MYGN 1995
  • Fundamental
  • Price
  • GOGL $8.86
  • MYGN $12.39
  • Analyst Decision
  • GOGL Hold
  • MYGN Hold
  • Analyst Count
  • GOGL 2
  • MYGN 12
  • Target Price
  • GOGL $12.25
  • MYGN $23.92
  • AVG Volume (30 Days)
  • GOGL 1.4M
  • MYGN 1.0M
  • Earning Date
  • GOGL 02-28-2025
  • MYGN 02-25-2025
  • Dividend Yield
  • GOGL 13.54%
  • MYGN N/A
  • EPS Growth
  • GOGL 102.13
  • MYGN N/A
  • EPS
  • GOGL 1.22
  • MYGN N/A
  • Revenue
  • GOGL $1,011,652,000.00
  • MYGN $823,600,000.00
  • Revenue This Year
  • GOGL N/A
  • MYGN $13.82
  • Revenue Next Year
  • GOGL $2.75
  • MYGN $4.59
  • P/E Ratio
  • GOGL $7.27
  • MYGN N/A
  • Revenue Growth
  • GOGL 14.81
  • MYGN 12.15
  • 52 Week Low
  • GOGL $8.52
  • MYGN $12.17
  • 52 Week High
  • GOGL $15.77
  • MYGN $29.30
  • Technical
  • Relative Strength Index (RSI)
  • GOGL 39.47
  • MYGN 29.80
  • Support Level
  • GOGL $9.07
  • MYGN $12.17
  • Resistance Level
  • GOGL $9.52
  • MYGN $15.08
  • Average True Range (ATR)
  • GOGL 0.22
  • MYGN 0.79
  • MACD
  • GOGL 0.07
  • MYGN -0.01
  • Stochastic Oscillator
  • GOGL 18.52
  • MYGN 7.56

About GOGL Golden Ocean Group Limited

Golden Ocean Group Ltd is a Bermuda-based dry bulk shipping company. Its business involves the transportation of dry bulk cargo including ores, coal, grains and fertilizers through its fleet of owned and chartered vessels, bareboat vessels, commercial management vessels and new buildings are chartered-out on fixed rate time charters and index-linked time charter contracts.

About MYGN Myriad Genetics Inc.

Myriad Genetics is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel with the capability to identify the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm offers biomarker discovery and companion diagnostic services to pharma and biotech companies.

Share on Social Networks: